MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 have?
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 has 135 citations in the OpenAlex counts ScholarIQ stores.
When was MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 published?
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 has 2016 year in the ScholarIQ index.
What is the open-access status of MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2?
MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 has diamond oa status in the ScholarIQ index.
What is the DOI of MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2?
The DOI for MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 is on the source record.
What is the PMID of MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2?
The PMID for MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 is on the source record.
What is the OpenAlex record for MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2?
The OpenAlex for MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 is on the source record.